AcquisitionOther
Elicio Therapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Elicio Therapeutics, Inc. -> target · $1.00
Angion’s common stock will begin trading on a split-adjusted basis when the market opens on June 2, 2023 under the new trading symbol “ELTX.” As a result of the reverse stock split, the CUSIP number for Angion’s common stock will now be 28657F103.
Open source record (SEC) ↗